Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gastrointestinal Cancers
Do you consider adjuvant radiation for low grade T1bN0 gallbladder adenocarcinoma with negative margins after oncologic resection?
The data is scarce- do you recommend chemotherapy only or would you consider RT for local control?
Answer from: Radiation Oncologist at Academic Institution
There are no data to support chemotherapy and especially not postoperative radiation.
Comments
Radiation Oncologist at Northeast Oklahoma Cancer Center
There is an absence of phase III data in this sett...
1171
Sign in or Register to read more
4911
Related Questions
When treating pancreatic body/tail lesions that result in significant dose spread to the spleen, what is your threshold to offer pneumococcal, hemophilus influenza, and meningococcal vaccines?
For a patient with T3N1M0 esophageal adenocarcinoma, who suffered esophageal perforation necessitating metallic stent placement, would you favor a neoadjuvant chemoradiation or perioperative chemotherapy approach?
What treatment sequence do you follow for patients with rectal cancer who are candidates for both PROSPECT and TNT/Watch and wait?
In which patients with early stage rectal cancer treated according to the PROSPECT paradigm do you recommend adjuvant chemotherapy?
Are you using vaginal dilators during treatment of rectal cancer to spare anterior vaginal wall, or are you reserving this for anal cancers?
What's your follow up protocol for a near complete response (nCR) in rectal patients considering non-operative management (NOM)?
Would you offer pelvic re-irradiation in the setting of locally recurrent anal cancer in the presacral region?
Which patients, if any, treated according to PROSPECT for an early stage rectal cancer, would you offer surveillance if they achieved cCR after neoadjuvant chemotherapy?
How would you approach unexpected chemo breaks during planned neoadjuvant chemoradiation for esophageal adenocarcinoma?
How do you approach repeat SBRT in the abdomen, specifically when considering constraints for bowel and mesenteric vessels?
There is an absence of phase III data in this sett...